BAYZF - Recursion Pharma draws Market Perform at TD Cowen despite AI potential
2024-01-26 15:14:24 ET
More on Recursion Pharmaceuticals
- Recursion Pharmaceuticals: More Hype Than Substance Amid Signs Of Progress
- Recursion Pharmaceuticals: Second Half 2024 Data Readouts Are Major Inflection Points
- Recursion Pharma spikes after licensing deal with Bayer
- Absci hits new 52-week high as race for AI drug discovery heats up
- Seeking Alpha’s Quant Rating on Recursion Pharmaceuticals